The plasma fractionation market in Vietnam is majorly driven by prevailing disease conditions in the population, coupled with growth in geriatric individuals vulnerable to many diseases, thereby, leading to rise in demand for plasma derived approaches to treat diseases, specifically immune and neurological disorders. Moreover, plasma derived treatments are precise and proteins used in the procedures possess properties that are unique to them. As a result, there are fewer substitutes available in the market. However, considerable regulatory burden on manufacturing and logistics of plasma fractionation is expected to impede the market growth in Vietnam. —
Vietnam plasma fractionation market generated $56.62 million in 2019, and is estimated to reach $79.03 million by 2027, portraying a CAGR of 5.3% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios.
Download Sample PDF Of Report: https://www.alliedmarketresearch.com/request-sample/6803
Growing population of ageing people across the country vulnerable to various medical disorders drive the growth of the Vietnam plasma fractionation market.The immunoglobulins segment contributed to the largest share in 2019,and is estimated to maintain its dominant position by 2027. The demand for plasma fractionation has increased during the Covid-19 pandemic due to surge in demand for blood plasma of recovered Covid-19 patients to treat the infected patients.
On the other hand, is a potentially large healthcare market wherein the presence of public sector is overpowering the private sector, comprising of more than 85% of the hospitals and commune health stations across the country. As per World Bank Group, Vietnam is considered as a middle-income country with a healthcare expenditure of 5.53% of its GDP.
Covid-19 scenario:-
- The demand for plasma fractionation has increased during the Covid-19 pandemic due to surge in demand for blood plasma of recovered Covid-19 patients to treat the infected patients.
- The demand for plasma fractionation would grow to increase the immunity of the aging patients suffering from primary -immunodeficiency disorders and neurological conditions.
- The report offers a detailed segmentation of the Vietnam plasma fractionation market based on product, application, and end user.
Based on product, the immunoglobulins segment contributed to the largest share in 2019, accounting for more than two-fifths of the total share, and is estimated to maintain its dominant position during the forecast period. However, the coagulation factor VIII segment is estimated to portray the highest CAGR of 6.3% during the forecast period.
Based on application, the neurology segment accounted for the largest share in 2019, holding more than two-fifths of the total share, and is expected to maintain the largest share throughout the forecast period. In addition, it is expected to register the highest CAGR of 5.9% from 2020 to 2027. The research also analyzes segments such as hematology, immunology, critical care, and others.
Based on end user, the hospitals segment accounted for the largest share in 2019, holding more than three-fourths of the total share, and is expected to maintain the largest share throughout the forecast period. In addition, itis expected to register the highest CAGR of 5.5% from 2020 to 2027. The report also analyzes the clinical research institutes segment.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6803
Leading market players analyzed in the research includes Biotest AG, Baxter International Inc.,Getz Healthcare,Bio Products Laboratory Ltd., KedrionBiopharma, Grifols SA, Novo Nordisk, Octapharma, Sanquin Blood Supply Foundation, and Sanova Healthcare.
Similar Reports:
Surgical Robotic Systems Market Global Opportunity Analysis and Industry Forecast, 2020-2027
Blood Culture Test market Global Opportunity Analysis and Industry Forecast, 2020-2027
Medical Thawing System Market Global Opportunity Analysis and Industry Forecast, 2020-2027
AI in Healthcare Market Global Opportunity Analysis and Industry Forecast, 2020-2027
Contact Info:
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Phone: 18007925285
Website: https://www.alliedmarketresearch.com/
Release ID: 89030450